Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers create pigs resistant to PRRS during reproduction
Researchers found that mothers without the CD163 protein are resistant to the PRRS virus.

Research could save the global pig industry millions

Researchers have used gene editing technology to protect offspring from porcine reproductive and respiratory (PRRS) virus during reproduction.

A study by Kansas State University found that mothers without the CD163 protein are resistant to the PRRS virus and give birth to healthy, normal piglets. The work is published in the journal Scientific Reports.

“We have created a protective shell against the PRRS virus during the reproductive phase of production,” said Bob Rowland, professor of diagnostic medicine and pathobiology at Kansas State University. “The offspring does not become infected during pregnancy and is born a healthy piglet. During this critical phase of production, we have essentially ended a disease.”

PRRS brings about disease in two forms: a respiratory form that makes it more difficult for pigs to breathe and a more severe form that causes mass death in pigs during late pregnancy. Besides having an enormous economic impact, the latter can also have a huge psychological impact on people who work with pigs.

To address the devastating reproductive form of the virus, the researchers set out to create PRRS-resistant pigs. Using CRISPR/Cas9 gene editing technology, they found that pigs without the CD163 protein showed no signs or evidence of being infected with the PRRS virus. CD163 is the receptor for the virus.

The team hopes that the research could save the global pig industry millions because pigs are protected from the PRRS virus during the critical reproductive process. However, because piglets are born normal, they may still be susceptible to disease later in life.

"This is one tool that we can use," Rowland said. "It doesn't mean that we can give up on vaccines or diagnostics, but it does create more opportunities for other tools to become more effective. Because this pig is born healthy, it will respond better to a vaccine or a diagnostic test. We are enhancing other aspects of disease control as well."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.